Month: March 2023

Total revenue for 2022 was approximately $2.6 million Balance sheet strengthened by recently closed public offering with gross proceeds of $7.5 million Conference call to be held March 29, 2023 at 4:30 p.m. ETROCKVILLE, Md., March 29, 2023 (GLOBE NEWSWIRE) — OpGen, Inc. (Nasdaq: OPGN, “OpGen” or “the Company”), a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease, reported today its fourth quarter 2022 and full-year 2022 financial and operating results and provided a business update. OpGen’s revenue for the fourth quarter of 2022 was approximately $722 thousand. Its total revenue for 2022 was approximately $2.6 million which was in line with the Company’s most recent guidance. “Overall, in 2022 there were several business advancements for OpGen with the...

Full year 2022 Revenue grew to $86.3 million, 10.6% higher compared to 2021 RENO, Nev., March 29, 2023 (GLOBE NEWSWIRE) — Dragonfly Energy Holdings Corp. (“Dragonfly” or the “Company”) (Nasdaq: DFLI), an industry leader in energy storage and producer of deep cycle lithium-ion storage batteries, today reported financial and operational results for the fourth quarter and full year of 2022. Fourth Quarter 2022 Financial HighlightsNet Sales of $20.2 million were unchanged compared to Q4 2021 Gross Profit of $4.4 million, decreased $1.7 million from $6.1 million in Q4 2021 Operating expenses of $(12.5) million, were higher compared to $(6.2) million in Q4 2021 EBITDA was a negative $(7.8) million, lower compared to $0.1 million in Q4 2021 Adjusted EBITDA was a negative $(4.8) million, compared $1.0 million in Q4 2021Full Year 2022...

Q4 2022 and Full-Year HighlightsAnnual revenue of $101 million, exceeding $100 million for the first time in View’s history, representing 37% year-over-year growth compared to annual revenue of $74 million in 2021 and within management guidance of $100 to $110 million. Record revenues of $44 million for Q4 2022, representing 56% year-over-year growth compared to $28 million in Q4 2021. As of January 1, 2023, View Smart Windows qualify for the Investment Tax Credit (ITC), a 30% to 50% U.S. Federal tax credit intended to drive widespread adoption of smart windows, similar to solar, wind and stand-alone storage technologies. View launched its residential product offering to capitalize on the large and growing opportunity for smart windows in the multi-family sector. View completed a $212 million financing through the sale of convertible...

— ENLIGHTEN I Pivotal Phase 3 Trial of LYR-210 in Pre-Surgical Chronic Rhinosinusitis (CRS) on Track to Complete Enrollment in mid-2023 — — Data from BEACON Phase 2 Trial of LYR-220 in Post-Surgical CRS Anticipated Q4 2023 — — Advancing In-House Manufacturing Capabilities to Prepare for Commercial Production — WATERTOWN, Mass., March 29, 2023 (GLOBE NEWSWIRE) — Lyra Therapeutics, Inc. (Nasdaq: LYRA) (“Lyra” or the “Company”), a clinical-stage biotechnology company developing innovative therapies for the localized treatment of chronic rhinosinusitis (CRS), today reported its financial results for the fourth quarter and full year ended December 31, 2022 and provided a corporate update. “2022 was a transformative year for Lyra. We initiated three clinical trials that we believe will build on the...

ATRC-101 continues to be well tolerated in ongoing Phase 1b trial; clinical activity observed in multiple tumor types; longer progression free survival observed in patients with high target expression Phase 2 go/no-go decisions for ATRC-101 expected by end-of-year APN-497444 and APN-346958 programs advancing with nomination of clinical candidates expected in 2023 Conference call and webcast with accompanying slides scheduled for today at 4:30 p.m. EDT SAN CARLOS, Calif., March 29, 2023 (GLOBE NEWSWIRE) — Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on developing novel therapeutics generated through a unique discovery platform based on interrogation of the active human immune response, today announced financial results for the fourth quarter and full-year ended December 31, 2022, and provided...

Conference Call on Thursday, March 30, 2023, at 4 p.m. ET RESTON, Va., March 29, 2023 (GLOBE NEWSWIRE) — Lightbridge Corporation (Nasdaq: LTBR), an advanced nuclear fuel technology company, announced its financial results for the year ended December 31, 2022 and provided an update on the Company’s continued progress. Significant Milestones in 2022 and year-to-date 2023 include:In February 2023, Lightbridge and Pacific Northwest National Laboratory (PNNL) announced the successful completion of work under the U.S. Department of Energy’s (DOE) Gateway for Accelerated Innovation in Nuclear (GAIN) voucher program to demonstrate Lightbridge’s nuclear fuel casting process using depleted uranium, a key step in manufacturing Lightbridge Fuel™.In February 2023, Lightbridge announced that a recently published peer-reviewed...

SAINT LAURENT, Quebec, March 29, 2023 (GLOBE NEWSWIRE) — IntelGenx Technologies Corp. (TSX:IGX)(OTCQB:IGXT) (the “Company” or “IntelGenx”) today reported financial results for the three- and twelve-month periods ended December 31, 2022. All dollar amounts are expressed in U.S. currency, unless otherwise indicated, and results are reported in accordance with United States generally accepted accounting principles except where noted otherwise. “The progress we made throughout 2022 has led us to now being potentially on the cusp of a stage of anticipated rapid growth,” commented Dr. Horst G. Zerbe, CEO of IntelGenx. “In April, we expect the FDA’s decisions on the Buprenorphine Buccal Film ANDA, as well as the RIZAFILM® NDA. On the development front, we are also looking forward to atai announcing topline...

– Q4 2022 Net Sales Grew 18% to a Record $15.0 million, Gross Margins Expanded +250bps and Operating Expenses Declined 10% – – Continued Double-Digit Net Sales Growth, Gross Margin Expansion and Operating Expense Reductions to Drive Positive Modified EBITDA and Cash Flow from Operations in 2023 – NORWALK, Conn., March 29, 2023 (GLOBE NEWSWIRE) — Reed’s, Inc. (OTCQX: REED) (“Reed’s” or the “Company”), owner of the nation’s leading portfolio of handcrafted, natural ginger beverages, is reporting financial results for the three and twelve months ended December 31, 2022. Q4 2022 Financial Highlights (vs. Q4 2021):Net sales increased 18% to $15.0 million. Gross profit increased 32% to $3.4 million, with gross margin improving 250 bps to 23%. Delivery and handling costs declined 11% to $3.44 per case. Selling,...

FREMONT, Calif., March 29, 2023 (GLOBE NEWSWIRE) — Actelis Networks, Inc. (NASDAQ: ASNS) (“Actelis” or the “Company”), a market leader in cyber-hardened, rapid deployment networking solutions for wide area IoT applications, today reported financial results for the fiscal full year 2022 ended December 31, 2022. Full Year 2022 Financial Highlights:Total revenue increased 3.3% year-over-year to $8.8 million for the full year ended December 31, 2022. Delivery of Sales to IoT- customers grew 31% year-over-year for the full year ended December 31, 2022, offset by a decline in Telco sales, as the Company’s strategic shift to IoT continues. Gross Margin remains consistent at 47% for the full year ended December 31, 2022, despite pressures from semiconductor and electronic component lead times and purchase price variance. By the end of...